Nasopharyngeal carcinoma (NPC) is an aggressive malignant tumour of the head and neck region with a distinct geographic and ethnic distribution. Its development is often associated with genetic alterations, viral infections such as Epstein-Barr virus (EBV), and environmental factors. Among the molecular markers implicated in its pathogenesis, the tumour suppressor protein p53 plays a critical role in regulating cell cycle, DNA repair, and apoptosis. Aberrant expression of p53 has been reported in various malignancies, including NPC, and may provide important diagnostic, prognostic, and therapeutic implications. This study investigates the immunohistochemical expression of p53 in nasopharyngeal carcinoma cases diagnosed at the National Hospital, Abuja. Formalin-fixed, paraffin-embedded tissue samples of confirmed NPC were retrieved and subjected to immunohistochemical staining using monoclonal antibodies specific for p53. The expression pattern was evaluated based on nuclear staining intensity and percentage of positive tumour cells, and results were correlated with clinicopathological parameters such as age, sex, and histological subtype. Findings from this study revealed that a significant proportion of NPC cases showed overexpression of p53 protein, suggesting possible involvement of p53 pathway alterations in the tumorigenesis of NPC among Nigerian patients. The expression was more pronounced in undifferentiated carcinoma compared to differentiated subtypes, with no significant gender variation. The study concludes that p53 overexpression is common in NPC in Abuja and may serve as a useful biomarker in understanding tumour biology, prognosis, and in guiding therapeutic strategies. It further recommends larger multicenter studies incorporating molecular assays to validate the prognostic significance of p53 in NPC within the Nigerian population.